DalsnaFinance › IPOs › Denali Therapeutics Inc › IPO

Denali Therapeutics Inc. IPO

Completed

Denali Therapeutics Inc. completed its initial public offering on NASDAQ on December 8, 2017, pricing at $18.00 a share.

Ticker	DNLI
Exchange	NASDAQ
Status	Completed
Listing date	December 8, 2017
Offering price	$18.00
Shares offered	13,888,888
Total raised	$250M

The offering

Denali Therapeutics Inc. sold 13,888,888 shares at $18.00 each on NASDAQ. Multiplied out, that is $250 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $250 million total recorded for the deal.

Company coverage

Denali Therapeutics Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for Denali Therapeutics Inc.. This page is general information, not investment advice.